尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Cunningham Kenneth, Director. Insider active across 1 company, notably Verona Pharma plc. In total, 3 reports have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €9k. Activity tracked since 4 May 2021. The latest transaction was filed on 1 August 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Kenneth Cunningham is a Board Member at Verona Pharma plc. He plays an important role in the governance of the company, providing his expertise and strategic advice. His commitment to best practices in corporate governance contributes to the strength and transparency of the company's operations. He is involved in key decision-making that influences the future direction of the company.